Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens
Location: East Bay
Please contact Julian De la Cruz
Principal Investigator
Related Studies
Pilot Project in Applied Artificial Intelligence: Using Machine Learning to Improve the Safety of Hospital Care
Investigator: Sylvia Sudat, PhD